BioWorld MedTech

Aug. 14, 2014

First U.S. commercial Neuraceq scan for beta-amyloid plaque imaging

Piramal Imaging (Berlin) reported that WVU Healthcare (Morgantown, West Virginia) is the first U.S. center to perform commercial scans using the company's Neuraceq, which just became available for commercial use on Aug. 1. Read More

Asia in the Spotlight: High disease rate burden spurs Indian researchers in race to develop TB tests

Inside the Beltway: CMS considers HIV screening for all Medicare beneficiaries

Report from Europe: German law requires manufacturers provide implant card for patients

Financings: Castle raises $11.8M to expand availability of its cancer tests

Agreement/contracts: Alignment Healthcare to help out the Tar Heel State

Hit Bits: ZixCorp to provide UCHealth e-mail services across its healthcare system

Daily M&A: St. Jude Medical completes $200 million NeuroTherm buy

Patent Watch: Imris gets three Japanese patents for iMRI solution

World in Review: Study strongly supports value of screening for atherosclerosis

Product briefs

People in Places

MDD's Orthopedics Extra

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...